US paid Novavax $1.6B to make COVID vaccines. It’s given 7,300 shots in US
[ad_1] After so much hype, it turns out vaccine manufacturer Novavax’s long-awaited COVID jab hit the market far too late. In its second quarter earnings on Monday, Novavax announced sales…